Article
Targeting of BMI-1 with PTC-209 inhibits glioblastoma development
19 May 2018
Abstract excerpt
Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor and refractory to existing therapies. The oncogene BMI-1, a member of Polycomb Repressive Complex 1 (PRC1) plays essential roles in various human cancers and becomes an attractive therapeutic target. Here we showed that BMI-1 is highly expressed in GBM and especially enriched in glioblastoma stem cells (GSCs). Then we comprehensively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
